Astera Labs, Inc. $ALAB Shares Bought by ProShare Advisors LLC

ProShare Advisors LLC raised its stake in Astera Labs, Inc. (NASDAQ:ALABFree Report) by 40.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 16,751 shares of the company’s stock after purchasing an additional 4,802 shares during the quarter. ProShare Advisors LLC’s holdings in Astera Labs were worth $2,787,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the stock. Assetmark Inc. raised its stake in shares of Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after acquiring an additional 101 shares during the period. Hilltop National Bank raised its stake in shares of Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after acquiring an additional 100 shares during the period. Aventura Private Wealth LLC purchased a new position in shares of Astera Labs in the 4th quarter valued at $33,000. National Bank of Canada FI raised its stake in shares of Astera Labs by 159.0% in the 3rd quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after acquiring an additional 124 shares during the period. Finally, Wexford Capital LP purchased a new position in shares of Astera Labs in the 3rd quarter valued at $39,000. Institutional investors and hedge funds own 60.47% of the company’s stock.

Insider Activity

In related news, COO Sanjay Gajendra sold 280,000 shares of Astera Labs stock in a transaction on Tuesday, May 19th. The shares were sold at an average price of $249.19, for a total transaction of $69,773,200.00. Following the sale, the chief operating officer owned 615,000 shares of the company’s stock, valued at $153,251,850. The trade was a 31.28% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 28,737 shares of Astera Labs stock in a transaction on Tuesday, May 19th. The stock was sold at an average price of $249.62, for a total transaction of $7,173,329.94. Following the sale, the chief executive officer directly owned 3,789,232 shares in the company, valued at $945,868,091.84. This trade represents a 0.75% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders sold 1,915,461 shares of company stock worth $358,508,976. Corporate insiders own 12.50% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently commented on ALAB. Evercore reissued an “outperform” rating and issued a $297.00 target price on shares of Astera Labs in a research note on Tuesday, May 19th. Loop Capital began coverage on shares of Astera Labs in a research note on Thursday, March 5th. They issued a “buy” rating and a $250.00 target price on the stock. Roth Mkm reissued a “buy” rating and issued a $275.00 target price on shares of Astera Labs in a research note on Wednesday, May 6th. Barclays raised their target price on shares of Astera Labs from $165.00 to $200.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. Finally, Needham & Company LLC raised their target price on shares of Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $233.75.

View Our Latest Research Report on Astera Labs

Astera Labs Price Performance

Astera Labs stock opened at $306.88 on Monday. Astera Labs, Inc. has a 12-month low of $84.78 and a 12-month high of $315.81. The company has a market capitalization of $52.60 billion, a price-to-earnings ratio of 207.35, a price-to-earnings-growth ratio of 4.06 and a beta of 3.35. The firm’s fifty day moving average price is $170.39 and its 200 day moving average price is $159.57.

Astera Labs (NASDAQ:ALABGet Free Report) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same quarter in the previous year, the firm posted $0.33 EPS. The firm’s quarterly revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Analysts forecast that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

  • Positive Sentiment: Evercore ISI raised its price target on Astera Labs to $297 from $215 and kept an Outperform rating after updated AI channel checks, reinforcing the market’s view that ALAB is benefiting from strong AI infrastructure demand. Article Title
  • Positive Sentiment: Multiple reports point to momentum from the AI inference boom, with traders and investors buying into the stock after bullish coverage, elevated call activity, and a “golden cross” technical breakout that can attract trend-following buyers. Article Title
  • Positive Sentiment: Recent commentary highlighted Astera Labs as a beneficiary of rising AI infrastructure spending, supporting the stock’s move higher and helping it reach fresh highs. Article Title
  • Neutral Sentiment: Executives including the CEO, COO, and general counsel disclosed large share sales, but several transactions were tied to pre-arranged 10b5-1 plans or tax withholding on equity awards, which makes the selling less conclusive as a bearish signal. Article Title

About Astera Labs

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Articles

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.